SCHEMBL6484067

SCHEMBL6484067

c1c[nH]c(CN2CC[N]CC2)n1

nearest known ligand 0.79

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
ALOX15 P16050 1/20 0.79
HTR1D P28221 1/20 0.39
HTR1B P28222 1/20 0.39
EGLN1 Q9GZT9 1/20 0.39
TAAR1 Q96RJ0 5/20 0.38
PARP1 P09874 1/20 0.37
KAT2B Q92831 1/20 0.36
TERT O14746 1/20 0.36
ALDH1A1 P00352 2/20 0.36
KDM4E B2RXH2 1/20 0.35
LMNA P02545 1/20 0.35
HTR4 Q13639 1/20 0.35
KCNH2 Q12809 1/20 0.34
FDPS P14324 1/20 0.34
POLB P06746 1/20 0.34
GAA P10253 1/20 0.34
MAPT P10636 1/20 0.34
TDP1 Q9NUW8 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3553264 0.93 ALOX15 (0.69) ALOX15HTR1DHTR1BEGLN1TAAR1
SCHEMBL15329166 0.88 ALOX15 (1.00) ALOX15HTR1DHTR1BEGLN1TAAR1
SCHEMBL1953418 0.85 ALOX15 (0.85) ALOX15HTR1DHTR1BEGLN1TAAR1
SCHEMBL4515060 0.85 ALOX15 (0.85) ALOX15HTR1DHTR1BEGLN1TAAR1
SCHEMBL807358 0.83 ALOX15 (0.81) ALOX15HTR1DHTR1BEGLN1TAAR1
SCHEMBL18325377 0.83 ALOX15 (0.81) ALOX15HTR1DHTR1BEGLN1TAAR1
SCHEMBL4731563 0.81 ALOX15 (0.79) ALOX15HTR1DHTR1BEGLN1TAAR1
SCHEMBL5709857 0.81 ALOX15 (0.79) ALOX15HTR1DHTR1BEGLN1TAAR1
SCHEMBL24672614 0.80 ALOX15 (0.82) ALOX15HTR1DHTR1BEGLN1TAAR1
SCHEMBL7278898 0.80 ALOX15 (0.76) ALOX15HTR1DHTR1BEGLN1ALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6969712-B2 Benzimidazole derivatives BANYU PHARMACEUTICAL CO., LTD. (JP) 2005-11-29 US disclosed
US-20040044056-A1 Benzimidazole derivatives BANYU PHARMACEUTICAL CO., LTD. (JP) 2004-03-04 US disclosed
EP-1342717-A1 BENZIMIDAZOLE DERIVATIVES BANYU PHARMACEUTICAL CO., LTD. (JP) 2003-09-10 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20040044056-A1 Benzimidazole derivatives GPR119, OPRL1, INSR ALOX15 1836/4885HTR1D 85/4885HTR1B 64/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.